The prospective role of plant products in radiotherapy of cancer: A current overview

35Citations
Citations of this article
108Readers
Mendeley users who have this article in their library.

Abstract

Treatment of cancer often requires exposure to radiation, which has several limitations involving non-specific toxicity toward normal cells, reducing the efficacy of treatment. Efforts are going on to find chemical compounds which would effectively offer protection to the normal tissues after radiation exposure during radiotherapy of cancer. In this regard, plant-derived compounds might serve as " leads" to design ideal radioprotectors/radiosensitizers. This article reviews some of the recent findings on prospective medicinal plants, phytochemicals, and their analogs, based on both in vitro and in vivo tumor models especially focused with relevance to cancer radiotherapy. Also, pertinent discussion has been presented on the molecular mechanism of apoptotic death in relation to the oxidative stress in cancer cells induced by some of these plant samples and their active constituents. © Hazra, Ghosh, Kumar and Pandey.

Cite

CITATION STYLE

APA

Hazra, B., Ghosh, S., Kumar, A., & Pandey, B. N. (2012). The prospective role of plant products in radiotherapy of cancer: A current overview. Frontiers in Pharmacology, 3 JAN. https://doi.org/10.3389/fphar.2011.00094

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free